Expressions of Glucagon and Neuropeptide Y in Α Cells of Pancreatic Islets in Rats with Impaired Glucose Tolerance

李军,李秀钧,张杰,罗梅,周桥,赵桂芝
DOI: https://doi.org/10.3760/j.issn:1000-6699.2004.03.002
2004-01-01
Abstract:Objective To measure and compare glucagon (GLC) and neuropeptide Y (NPY) expressions of islet α cells, insulin (INS) expression of islet β cells and NPY mRNA expression in pancreatic islets in rat models of insulin resistance (IR), impaired glucose tolerance (IGT) and type 2 diabetes mellitus (DM), and to determine the existence of IR of α cells in rat models. Methods Rat models of IR, IGT and type 2 DM were established with high fat diet/buffer or high fat diet/low dose streptozotocin. With these rat models, the distributions and concentrations of NPY and GLC of α cells and INS of β cells were measured by double-labelled immunofluorescence staining and single-labelled immunofluorescence staining respectively, and the contents of NPY mRNA in islets were determined by in situ hybridization (ISH). Results The biochemical and metabolic characteristics and the pathogenesis processes of rat models were consistent with clinical feature of related diseases. As compared with the mean optical density (MOD) of GLC and NPY expressions of α cells in normal control (NC) group (687±127 and 275±14 respectively), the MOD of GLC and NPY in IR group (1755±226, 646±122), IGT group (1720±108, 599±63) and type 2 DM group (1986±88, 585±67) were significantly increased (all P0.01). The MOD of INS expression of β cells in IR group (2073±340), IGT group (1976±200) and type 2 DM group (1709±184) were all higher than that in NC group (1425±220) (P0.01, P0.01 and P0.05, respectively). The expessions of NPY and GLC in α cells were increased and the distribution of these α cells changed from peripheral site of islet to the whole islet. The expression of NPY mRNA was not found in islets of NC group, but distributed in the whole islets of IR, IGT and type 2 DM groups. Conclusion The elevated expressions of GLC and NPY were not suppressed by endogenous hyperinsulinism in IR, IGT and type 2 DM groups, strongly supporting the hypothesis that the endogenous insulin resistance of islet α cells exists in these groups.
What problem does this paper attempt to address?